Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Ma

Showing results (931-940 of 1,764) with videos related to

Pageof 177
Sort By:
Chemotherapy|August 20, 2010
Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanesYing Fan, Binghe Xu, Peng Yuan, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 28, 2017
Association of Heparin-binding EGF-like Growth Factor Polymorphisms With Necrotizing Enterocolitis in Preterm InfantsFei Ma, Sitao Li, Hu Hao, et al.
Journal of Comparative Effectiveness Research|August 29, 2025
Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancerStephen Chia, Jie Li, Fei Ma, et al.
Journal of Cancer Research and Therapeutics|October 7, 2022
Circ-CCS enhances autophagy during imatinib resistance of gastrointestinal stromal tumor by regulating miR-197-3p/ATG10 signalingShujing Sui, Fei Ma, Lei Mi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 1, 2015
MiR-34b/c rs4938723 Polymorphism Significantly Decreases the Risk of Digestive Tract Cancer: Meta-analysisTian-Xing Ji, Cheng Zhi, Xue-Guang Guo, et al.
Medicine|November 19, 2015
Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast CancerYing Fan, Xiaoyan Ding, Binghe Xu, et al.
Neonatology|March 13, 2022
Potential for CCR9+ IL-17+ Regulatory T Cell as a Predictor of Early Necrotizing EnterocolitisFei Li, Hu Hao, Xiaoyan Gao, et al.
BMC Physiology|May 27, 2017
Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4Fei Ma, Dimitrios E Kouzoukas, Katherine L Meyer-Siegler, et al.
CNS & Neurological Disorders Drug Targets|June 14, 2018
Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic StrokeShan Wang, Fei Ma, Longjian Huang, et al.
Phytotherapy Research : PTR|April 22, 2021
Sarsasapogenin ameliorates diabetes-associated memory impairment and neuroinflammation through down-regulation of PAR-1 receptorLi Kong, Yue Liu, Yu-Meng Zhang, et al.
Pageof 177

Showing results (931-940 of 1,764) with videos related to

Sort By:
Pageof 177
Chemotherapy|August 20, 2010
Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanesYing Fan, Binghe Xu, Peng Yuan, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 28, 2017
Association of Heparin-binding EGF-like Growth Factor Polymorphisms With Necrotizing Enterocolitis in Preterm InfantsFei Ma, Sitao Li, Hu Hao, et al.
Journal of Comparative Effectiveness Research|August 29, 2025
Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancerStephen Chia, Jie Li, Fei Ma, et al.
Journal of Cancer Research and Therapeutics|October 7, 2022
Circ-CCS enhances autophagy during imatinib resistance of gastrointestinal stromal tumor by regulating miR-197-3p/ATG10 signalingShujing Sui, Fei Ma, Lei Mi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 1, 2015
MiR-34b/c rs4938723 Polymorphism Significantly Decreases the Risk of Digestive Tract Cancer: Meta-analysisTian-Xing Ji, Cheng Zhi, Xue-Guang Guo, et al.
Medicine|November 19, 2015
Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast CancerYing Fan, Xiaoyan Ding, Binghe Xu, et al.
Neonatology|March 13, 2022
Potential for CCR9+ IL-17+ Regulatory T Cell as a Predictor of Early Necrotizing EnterocolitisFei Li, Hu Hao, Xiaoyan Gao, et al.
BMC Physiology|May 27, 2017
Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4Fei Ma, Dimitrios E Kouzoukas, Katherine L Meyer-Siegler, et al.
CNS & Neurological Disorders Drug Targets|June 14, 2018
Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic StrokeShan Wang, Fei Ma, Longjian Huang, et al.
Phytotherapy Research : PTR|April 22, 2021
Sarsasapogenin ameliorates diabetes-associated memory impairment and neuroinflammation through down-regulation of PAR-1 receptorLi Kong, Yue Liu, Yu-Meng Zhang, et al.
Pageof 177